ONESOURCE SPECIALTY PHARMA
|
The Current P/B Ratio of ONESOURCE SPECIALTY PHARMA is 2.09.
Share Price | ₹1,587.4 | Apr 02,2025 |
Market Cap | ₹18,159.3 Cr | |
Book Value | ₹8,695.7 Cr | Mar2024 - Standalone Results |
Price/Book | 2.09x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of ONESOURCE SPECIALTY PHARMA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹18,159.3 Cr] as on Apr 02,2025
(/) Book Value [ ₹8,695.7 Cr] based on Mar2024 - Standalone Results
(=) P/B Ratio [ 2.09x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '2.09 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/B Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PB (Price/Book ) ratio chart of ONESOURCE SPECIALTY PHARMA
PB Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/b ratio for fiscal years ending to Apr 02,2025 averaged nanx.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/b ratio of x from fiscal years ending March 2018 to 2022.
- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/b ratio peaked in at x.
- ONESOURCE SPECIALTY PHARMA 's p/b ratio hit its five-year low in of x.
How does ONESOURCE SPECIALTY PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
ONESOURCE SPECIALTY PHARMA | 8,695.70 | 2.09 | 18,159.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.46 | 411,306.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.08 | 150,343.0 |
CIPLA LTD | 26,619.90 | 4.41 | 117,323.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.84 | 108,619.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.41 | 95,941.5 |
MANKIND PHARMA LTD | 9,339.84 | 10.70 | 99,891.5 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.52 | 89,680.6 |
LUPIN LTD | 14,175.80 | 6.47 | 91,742.2 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.25 | 67,294.6 |
ABBOTT INDIA LTD | 3,658.73 | 17.18 | 62,839.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs ONESOURCE SPECIALTY PHARMA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.09x |
Max industry PB | 17.18x |
Median industry PB | 6.46x |
Average industry PB | 7.67x |
You may also like the below Video Courses